Core Viewpoint - Suzhou Pusiying Medical Technology Co., Ltd. has completed nearly 100 million yuan in Series A financing, which will be used to accelerate the industrialization of its low-helium siphon cooling technology PhaseXCool® in superconducting magnet devices, including MRI equipment, industrial magnetic crystal growth systems, and precision scientific instruments [2][8]. Group 1: Company Overview - Pusiying aims to become a platform-level technology company capable of creating extreme physical environments such as ultra-low temperatures, high vacuum, and strong magnetic fields [5][6]. - The company has core technological advantages in electromagnetic and thermal field coupling simulation design, low-temperature engineering technology in the liquid helium region, and extensive practical experience in engineering mass production and self-developed components [6][8]. Group 2: Technological Innovations - The MRI core component's superconducting magnet requires operation in extreme low-temperature environments below -268.95 degrees Celsius (4.2K). Traditional methods rely heavily on liquid helium, which poses a significant bottleneck for domestic MRI development due to over 95% import dependency and rising prices [8][9]. - Pusiying has developed a 1.5T/930mm large temperature aperture low-liquid-helium superconducting magnet system, reducing the lifecycle liquid helium demand by over 90% and eliminating the need for refills throughout its lifetime [8][9]. - The PhaseXCool® technology requires only 1% of the liquid helium compared to traditional methods, allowing for flexible replacement with nitrogen or argon as cooling media, thus adapting to various low-temperature needs [9][10]. Group 3: Market Position and Collaborations - The company has established partnerships with several leading medical device groups and is advancing the development of next-generation high-field magnets to support the localization of high-end medical equipment and accessibility for grassroots hospitals [10][11]. - Pusiying's core technology is not limited to low-temperature superconducting magnets for medical applications but can also be applied to high-temperature superconducting materials in liquid nitrogen temperature ranges, showcasing strong extensibility [11]. Group 4: Cost and Safety Advantages - The technology revolutionizes costs by eliminating the need for liquid helium refills, reducing overall operational costs by 50%, and significantly lowering procurement and maintenance barriers for hospitals [14]. - The closed-loop system provides automatic fault protection, eliminating the risk of liquid helium leakage and reducing downtime recovery time to one-third of traditional equipment [14]. Group 5: Future Prospects - Pusiying is collaborating with Fudan University to develop a high-field mass spectrometry magnet system and is involved in joint research projects for high-temperature superconducting materials, addressing domestic needs for high-field magnet applications [11][18]. - The company is expected to leverage its technological advantages to achieve breakthroughs in both medical and industrial fields, aspiring to become a world-class technology company alongside Oxford Instruments and Bruker [18].

Core Insights - Suzhou Pusi Ying Medical recently completed nearly 100 million yuan Series A financing, led by Ivy Capital, with continued investment from existing shareholder Neusoft Capital and participation from Xiaoming Investment [1] - The funding will accelerate the industrialization and expansion of the low helium siphon cooling technology PhaseXCool® in three main areas: medical MRI equipment, industrial magnetic single crystal superconducting systems, and precision scientific instruments [1] Company Overview - The founder, Dr. Ni Zhipeng, has a career focused on superconducting magnets, achieving breakthroughs in superconducting magnet research at institutions such as the Chinese Academy of Sciences and Philips Healthcare [1] - Pusi Ying Medical aims to develop domestic low liquid helium superconducting magnet technology to achieve technological advancement [1] Technology Breakthrough - The new generation of low liquid helium magnets eliminates excessive reliance on liquid helium by using a GM refrigerator secondary cold head (3-4K) as a cooling source, achieving efficient heat exchange for key components of the magnet [2] - The technology allows superconducting magnets to operate stably below 4.2K without liquid helium consumption, relying on a closed pipeline and heat exchanger for self-driven cooling [2] Structural and Cost Advantages - The new technology features structural design optimizations that reduce weight by nearly half, from 4.5-6 tons to approximately 3 tons, lowering manufacturing and installation barriers [2] - For hospitals, this means reduced infrastructure requirements, more flexible installation, and lower maintenance costs, while the overall operational costs can decrease by 50% due to significant savings on liquid helium [2]